ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

We aren’t showing our typical comparisons because the provider updated his/her state of practice after we conducted our analysis. The updated address appears on this page.

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,652Medicare Part D Prescriptions Filled, Including Refills
$437K Total Retail Price of All Prescriptions
387 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
FUROSEMIDE 320 286
LEVOTHYROXINE SODIUM 291 257
LISINOPRIL 245 219
SIMVASTATIN 224 218
WARFARIN SODIUM 220 204
AMLODIPINE BESYLATE 196 169
HYDROCODONE-ACETAMINOPHEN 190 108 S3
HYDROCHLOROTHIAZIDE 167 160
METOPROLOL SUCCINATE 164 161
OMEPRAZOLE 162 145
METFORMIN HCL 130 99
ATENOLOL 125 113
POTASSIUM CHLORIDE 125 121
ATORVASTATIN CALCIUM 122 112
METOPROLOL TARTRATE 117 96
PREDNISONE 116 89
LOSARTAN POTASSIUM 101 98
CITALOPRAM HBR 89 68
GLIMEPIRIDE 79 65
DIGOXIN 79 79
NAPROXEN 77 56
CLOPIDOGREL 71 63
ZOLPIDEM TARTRATE 70 56
GABAPENTIN 67 61
SPIRONOLACTONE 66 60
CARVEDILOL 64 63
ALLOPURINOL 64 60
PRAVASTATIN SODIUM 63 54
DIOVAN 62 49
TAMSULOSIN HCL 58 54
DONEPEZIL HCL 57 49
PLAVIX 55 51
SERTRALINE HCL 55 40
ISOSORBIDE MONONITRATE ER 55 55
DILTIAZEM 24HR CD 54 54
NAMENDA 53 53
CYCLOBENZAPRINE HCL 52 34 R
PRAMIPEXOLE DIHYDROCHLORIDE 51 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 2, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.